Aethlon Medical Inc

-0.02 (-1.11%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)27.41M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.12 Million
Adjusted EPS-$0.14
See more estimates
10-Day MA$1.85
50-Day MA$2.33
200-Day MA$3.24
See more pivots

Aethlon Medical Inc Stock, NASDAQ:AEMD

11555 Sorrento Valley Road, Suite 203, San Diego, California 92121
United States of America
Phone: +1.858.459.7800
Number of Employees: 10


Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.